112 related articles for article (PubMed ID: 7037821)
1. Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy.
Gourmelen M; Girard F; Binoux M
J Clin Endocrinol Metab; 1982 May; 54(5):885-92. PubMed ID: 7037821
[No Abstract] [Full Text] [Related]
2. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels.
Binoux M; Seurin D; Lassarre C; Gourmelen M
J Clin Endocrinol Metab; 1984 Sep; 59(3):453-62. PubMed ID: 6205015
[TBL] [Abstract][Full Text] [Related]
3. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders.
Bäckström M; Hall K; Sara V
Acta Endocrinol (Copenh); 1984 Oct; 107(2):171-8. PubMed ID: 6388207
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum.
Daughaday WH; Mariz IK; Blethen SL
J Clin Endocrinol Metab; 1980 Oct; 51(4):781-8. PubMed ID: 6998997
[No Abstract] [Full Text] [Related]
5. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
Blethen SL; Daughaday WH; Weldon VV
J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid effects on somatomedins and somatomedin inhibitors.
Unterman TG; Phillips LS
J Clin Endocrinol Metab; 1985 Oct; 61(4):618-26. PubMed ID: 4031007
[TBL] [Abstract][Full Text] [Related]
8. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.
Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M
Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of the IGF (insulin-like growth factors or somatomedins) competitive binding assay in the study of growth disorders in children (results for 124 observations) (author's transl)].
Gourmelen M; Girard F; Binoux M
Arch Fr Pediatr; 1980; 37 Suppl 2():XXXIII-XXXVIII. PubMed ID: 7447617
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor and its carrier protein in hypopituitary and hypothyroid children and adults.
Draznin B; Burstein PJ; Heinrich UE; Johnson CB; Emler CA; Schalch DS
Clin Endocrinol (Oxf); 1980 Feb; 12(2):137-42. PubMed ID: 6994937
[No Abstract] [Full Text] [Related]
11. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
[TBL] [Abstract][Full Text] [Related]
12. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia.
Daughaday WH; Trivedi B; Kapadia M
J Clin Endocrinol Metab; 1981 Aug; 53(2):289-94. PubMed ID: 7019228
[TBL] [Abstract][Full Text] [Related]
13. Somatomedin levels in childhood, adolescence and adult life.
Hall K; Sara VR
Clin Endocrinol Metab; 1984 Mar; 13(1):91-112. PubMed ID: 6327127
[No Abstract] [Full Text] [Related]
14. Characterization of an insulin-like growth factor-I/somatomedin-C radioimmunoassay specific for the C-peptide region.
Hintz RL; Liu F; Seegan G
J Clin Endocrinol Metab; 1982 Nov; 55(5):927-30. PubMed ID: 6749882
[TBL] [Abstract][Full Text] [Related]
15. Factors controlling blood concentration of somatomedin C.
Clemmons DR; Van Wyk JJ
Clin Endocrinol Metab; 1984 Mar; 13(1):113-43. PubMed ID: 6202444
[No Abstract] [Full Text] [Related]
16. A radioimmunoassay for insulin-like growth factor II specific for the C-peptide region.
Hintz RL; Liu F
J Clin Endocrinol Metab; 1982 Feb; 54(2):442-6. PubMed ID: 6172444
[TBL] [Abstract][Full Text] [Related]
17. Somatomedin-C and the assessment of growth.
Underwood LE; D'Ercole AJ; Van Wyk JJ
Pediatr Clin North Am; 1980 Nov; 27(4):771-82. PubMed ID: 7005847
[No Abstract] [Full Text] [Related]
18. Somatomedin A levels in patients with Cushing's disease.
Thorén M; Hall K; Rähn T
Acta Endocrinol (Copenh); 1981 May; 97(1):12-7. PubMed ID: 6261506
[TBL] [Abstract][Full Text] [Related]
19. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy.
Hintz RL; Liu F; Rosenfeld RG; Kemp SF
J Clin Endocrinol Metab; 1981 Jul; 53(1):100-4. PubMed ID: 6165729
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents.
Gourmelen M; Le Bouc Y; Girard F; Binoux M
J Clin Endocrinol Metab; 1984 Dec; 59(6):1197-203. PubMed ID: 6208211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
